© 2020 MJH Life Sciences™ and Cure Today. All rights reserved.
Bladder Cancer Advocacy Network | Advocacy Groups
Latest from Bladder Cancer Advocacy Network
How One Organization is Honoring Bladder Cancer Awareness Month During the COVID-19 Pandemic
May 14, 2020
Video
Amid the COVID-19 pandemic, the Bladder Cancer Advocacy Network is honoring Bladder Cancer Awareness Month in a slightly different way from previous years.
2020 Bladder Cancer Research Innovation Award
January 16, 2020
Article
The Bladder Cancer Advocacy Network announces it's Bladder Cancer Research Innovation Award.
FDA Grants Accelerated Approval to Astellas
January 14, 2020
Article
FDA has given an accelerated approval to Padcev in the treatment of patients with locally advanced or metastatic urothelial cancer.
Announcing BCAN 2020 Young Investigator Awards
January 11, 2020
Article
The Bladder Cancer Advocacy Network (BCAN) is pleased to announce two 2020 Young Investigator Awards (YIA), to support the development of outstanding early-career research scientists and clinical cancer research investigators.
Bladder Cancer Advocacy Network Turns 15
January 10, 2020
Video
At 15 years old the Bladder Cancer Advocacy Network looks back and takes a look ahead.
Bladder Cancer Advocacy Network Announces 2019 Bladder Cancer Research Innovation Awardee
July 08, 2019
Article
The Bladder Cancer Advocacy Network announced the recipient of its prestigious Bladder Cancer Research Innovation Award.
Latest News
FDA Accelerates Approval of Danyelza for Children and Adults with Relapsed or Refractory High-Risk Neuroblastoma
First-Line Treatment with Additional Combination Therapy After Resection May Improve Survival for Pancreatic Cancer
Keytruda With an Androgen Receptor Modulator May Produce a Modest Benefit in Women with Androgen Receptor-Positive, Triple-Negative Breast Cancer
Navigating Both Cancer and a Viral Pandemic Is a Difficult Balancing Act